Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Small Cell Lung Carcinoma 1Neurofibromatosis 2 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1DLBCL 1Carcinoma, Non-Small-Cell Lung 1Advanced Metastatic Breast Cancer 1

Interventions

Bevacizumab 3Lapatinib 2vistusertib 1brolucizumab 1aflibercept 1Vascular Endothelial Growth Factor A 1Sunitinib 1HDAC-42 1Everolimus 1Crizotinib 1Axitinib 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neurofibromatosis 2 × vistusertib × Clear all
NCT02831257 2022-06-13

AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas

Massachusetts General Hospital

Phase 2 Completed
18 enrolled 13 charts
CNS

Meningioma, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡